{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:08:51Z","timestamp":1782961731544,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Excellent Science and Technology Innovation Team Projects of Jiangsu Province Universities in 2015, China"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ejmech.2017.02.029","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T02:31:58Z","timestamp":1487298718000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Design, synthesis and biological evaluation of aminobenzyloxyarylamide derivatives as selective \u03ba opioid receptor antagonists"],"prefix":"10.1016","volume":"130","author":[{"given":"Junwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.02.029_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication","volume":"6","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejmech.2017.02.029_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1126\/science.274.5288.740","article-title":"Evidence-based health policy-Lessons from the global burden of disease study","volume":"5288","author":"Murray","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.02.029_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejmech.2017.02.029_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2017.02.029_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bmcl.2010.12.010","article-title":"Tetrahydroquinoline derivatives as opioid receptor antagonists","volume":"21","author":"Zhang","year":"2011","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.02.029_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0031-6997(25)06958-3","article-title":"International union of pharmacology. XII. Classification of opioid receptors","volume":"48","author":"Dhawan","year":"1996","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2017.02.029_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.lfs.2012.04.041","article-title":"Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand","volume":"90","author":"Parenti","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2017.02.029_bib8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2174\/0929867023369394","article-title":"Non-peptide opioid receptor ligands-recent advances, Part I-Agonists","volume":"9","author":"Kaczor","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.029_bib9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1517\/13543776.14.12.1725","article-title":"Kappa-opioid receptor ligands","volume":"12","author":"Husbands","year":"2004","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2017.02.029_bib10","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic. dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.02.029_bib11","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001","article-title":"Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens","volume":"21","author":"Pliakas","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2017.02.029_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2017.02.029_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of kappa-opioid receptor ligands on intracranial selfstimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2017.02.029_bib14","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1021\/jm015521r","article-title":"Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity","volume":"44","author":"Thomas","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.029_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2017.02.029_bib16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","article-title":"Anxiolytic-like effects of \u03ba-opioid receptor antagonists in models of unlearned and learned fear in rats","volume":"323","author":"Knoll","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2017.02.029_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.111.185108","article-title":"Pharmacological characterization of 2-methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)-propan-1-amine (PF-04455242), a high-affinity antagonist selective for kappa-opioid receptors","volume":"339","author":"Grimwood","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2017.02.029_bib18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jcph.286","article-title":"Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects","volume":"54","author":"Lowe","year":"2014","journal-title":"J.\u00a0Clin. Pharm."},{"key":"10.1016\/j.ejmech.2017.02.029_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2016.03.061","article-title":"Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test","volume":"781","author":"Huang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.02.029_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders","volume":"77","author":"Rorick-Kehn","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2017.02.029_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.pbb.2012.03.006","article-title":"The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats","volume":"101","author":"Deehan","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2017.02.029_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.npp.1301438","article-title":"Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence","volume":"33","author":"Walker","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2017.02.029_bib23","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2017.02.029_bib24","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1021\/jm200789r","article-title":"Discovery of aminobenzyloxyarylamides as kappa opioid receptor selective antagonists: application to preclinical development of a kappa opioid receptor antagonist receptor occupancy tracer","volume":"54","author":"Mitch","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.029_bib25","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.bmcl.2014.03.040","article-title":"Antagonists of the kappa opioid receptor","volume":"24","author":"Urbano","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.02.029_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human \u03ba-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2017.02.029_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1476-5381.1982.tb09319.x","article-title":"Spectrum of \u03bc, \u03b4, and \u03ba binding sites in homogenates of rat brain","volume":"77","author":"Gillan","year":"1982","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.02.029_bib28","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/0024-3205(88)90195-6","article-title":"[3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine","volume":"42","author":"Nock","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2017.02.029_bib29","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.02.029_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","article-title":"Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.02.029_bib31","first-page":"13447","article-title":"Diacylglycerol kinase \u03b2 knockout mice exhibit lithium sensitive behavioral abnormalities","volume":"5","author":"Kakefuda","year":"2010"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417300946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417300946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T12:49:42Z","timestamp":1749991782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417300946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"alternative-id":["S0223523417300946"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.02.029","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of aminobenzyloxyarylamide derivatives as selective \u03ba opioid receptor antagonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}